Women's Health Weekly
Our news journalists obtained a quote from the research, "To our knowledge, no studies have evaluated whether TH could be effectively used in AFE, and its use for this indication has not been described previously. We describe the case of a 32-year-old woman, who developed clinical manifestations of AFE and suffered a CA in the 29th week of her pregnancy. She received prolonged CPR (40 minutes until ROSC) and remained comatose. TH was induced and maintained for a total of 60 hours using an endovascular device, followed by controlled rewarming and maintenance of strict normothermia."
According to the news editors, the research concluded: "The patient survived and was neurologically intact (CPC 1) at 6 months of follow up."
For more information on this research see: Therapeutic hypothermia for cardiovascular collapse and severe respiratory distress after amniotic fluid embolism. Therapeutic Hypothermia and Temperature Management, 2014;4(2):96-8. (
Our news journalists report that additional information may be obtained by contacting
Keywords for this news article include:
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC
Articles featured in Life Extension Daily News are derived from a variety of news sources and are provided as a service by Life Extension. These articles, while of potential interest to readers of Life Extension Daily News, do not necessarily represent the opinions nor constitute the advice of Life Extension.